Orthopedic Braces And Supports - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the orthopedic braces and supports market size was valued at USD 4.81 billion in 2025 and is estimated to grow from USD 4.99 billion in 2026 to reach USD 6.12 billion by 2031, at a CAGR of 4.18% during the forecast period (2026-2031).

This report is Segmented by Product Type (Knee, Ankle & Foot, Back & Spine, Upper-Extremity, Hip & Pelvic, Others), Application (Ligament Injury, Preventive Care, Post-Op Rehabilitation, Osteoarthritis, Other Conditions), End User (Hospitals, Clinics, Homecare, Sports Centers), and Geography (North America, Europe, Asia-Pacific, MEA, South America). Market Forecasts are in Value (USD).

Global Orthopedic Braces And Supports Market Trends and Insights

Rising Prevalence of Osteoarthritis & MSDs

Global osteoarthritis prevalence climbed 113% between 1990 and 2020 and is projected to reach 1 billion cases by 2050, ensuring a large, recurring user base for knee and hip bracing. Middle-income Asia and Latin America will supply most net new cases, favoring low-cost sleeves, whereas mature payers in North America reimburse custom unloaders. In 2024 the CDC confirmed 58.5 million U.S. adults carried an arthritis diagnosis, underpinning a predictable brace replacement cycle. Vendors that segment portfolios by price tier can capture both cash-pay demand and reimbursed premium demand. Disease-driven baseline turnover thus anchors the orthopedic braces and supports market.

Growing Geriatric Population

By 2025, 29% of Japan's population was aged 65 and older, underscoring the need for lightweight ankle-foot orthoses compatible with robotic gait aids. Globally, the 60-plus cohort hit 1.4 billion in 2025 and will reach 2.1 billion by 2050. Older adults consume braces at higher per-capita rates, yet payers encourage preventive bracing that delays costly surgery. Europe's dependency ratio, climbing from 34% in 2025 to 57% by 2050, heightens fiscal pressure, spurring policy support for home-based supports that maintain mobility.

High Cost of Sophisticated Braces

Custom unloaders cost USD 600-800, while smart braces top USD 1,200, pricing out self-pay buyers in India, Indonesia, and Brazil. WHO data show out-of-pocket spending exceeds 50% of health expenditure in 35 LMICs, capping premium penetration. Tiered offerings, such as Ossur's polypropylene "Select" line, which trims bill-of-materials by 40%, aim to bridge the gap.

Other drivers and restraints analyzed in the detailed report include:

1. Increasing Sports-Related Injuries
2. Advancements in Lightweight Materials
3. Reimbursement Hurdles for OTC Products

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Knee braces retained a commanding 36.11% share of the orthopedic braces and supports market in 2025, buoyed by widespread ACL injuries and medial knee osteoarthritis. However, upper-extremity devices, led by shoulder and elbow supports, are forecast to grow at a 6.06% CAGR through 2031, outstripping all other categories. Rotator cuff repairs in the United States rose 8% year-on-year in 2024, driving sustained demand for abduction pillows and slings. Youth baseball guidelines further normalize prophylactic elbow bracing, extending replacement cycles.

Ankle and foot bracing is polarizing between low-cost elastic sleeves and custom ankle-foot orthoses for drop-foot. Zimmer Biomet's 2025 acquisition of Paragon 28 underlines its bet on specialty extremity growth. Lumbar-sacral orthoses face tighter CMS coverage, lengthening approval timelines. Niche hip and pelvic solutions remain tethered to post-surgery protocols and have limited uptake for osteoarthritis.

Complete Report Scope:

• By Product Type
  • Knee Braces & Supports
  • Ankle & Foot Braces
  • Back & Spine Braces
  • Upper-extremity Braces
  • Hip & Pelvic Braces
  • Others
• By Application
  • Ligament Injury
  • Preventive Care
  • Post-operative Rehabilitation
  • Osteoarthritis
  • Other Chronic Conditions
• By End User
  • Hospitals & Surgical Centers
  • Orthopedic Clinics
  • Homecare Settings
  • Sports & Rehabilitation Centers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

Asia-Pacific is projected to post a 7.27% CAGR from 2026-2031, outpacing every other region. China cut Class II orthotic review times to nine months in 2024, aligning documentation with ISO 13485 and lowering barriers for multinationals. India's Production Linked Incentive scheme offers a 5% rebate on incremental domestic sales, encouraging global brands to set up local production lines. Japan's super-aged society drives adoption of light, low-profile devices compatible with robotic exoskeletons, reinforcing the smart-brace frontier.

North America, anchored by Medicare DMEPOS reimbursement, retained a 39.78% share in 2025 but faces future margin compression from nationwide competitive bidding starting in 2028. Europe fragments along reimbursement lines; Wales' GBP 7.6 million framework in 2024 sliced procurement costs 12% while standardizing pathways. The Middle East invests in sports clinics ahead of major events, whereas South America charts divergent paths: Brazil expands SUS reimbursement, while Argentina prioritizes locally made elastic supports amid currency curbs.

1. 3M
2. Alcare Co., Ltd.
3. Bauerfeind
4. Bird & Cronin
5. Breg
6. BSN Medical
7. DePuy Synthes (J&J)
8. DeRoyal Industries
9. Dynatronics Corp.
10. Enovis (DJO)
11. Lohmann & Rauscher
12. medi
13. Ossur
14. Ottobock
15. Reh4Mat
16. Thuasne
17. Trulife
18. Tynor Orthotics
19. United Ortho
20. Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support